These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35683024)

  • 1. Repurposing Histaminergic Drugs in Multiple Sclerosis.
    Amadio S; Conte F; Esposito G; Fiscon G; Paci P; Volonté C
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35683024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis.
    Fiscon G; Conte F; Amadio S; Volonté C; Paci P
    Neurotherapeutics; 2021 Jul; 18(3):1678-1691. PubMed ID: 33987813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine pharmacology and new CNS drug targets.
    Tiligada E; Kyriakidis K; Chazot PL; Passani MB
    CNS Neurosci Ther; 2011 Dec; 17(6):620-8. PubMed ID: 22070192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Neuropharmacology; 2010 Sep; 59(3):180-9. PubMed ID: 20493888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Histamine and Multiple Sclerosis Alliance: Pleiotropic Actions and Functional Validation.
    Volonté C; Apolloni S; Amadio S
    Curr Top Behav Neurosci; 2022; 59():217-239. PubMed ID: 34432258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.
    Chen Y; Zhen W; Guo T; Zhao Y; Liu A; Rubio JP; Krull D; Richardson JC; Lu H; Wang R
    PLoS One; 2017; 12(12):e0189380. PubMed ID: 29253893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAveRUNNER: an R-based tool for drug repurposing.
    Fiscon G; Paci P
    BMC Bioinformatics; 2021 Mar; 22(1):150. PubMed ID: 33757425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models.
    Nyamoya S; Leopold P; Becker B; Beyer C; Hustadt F; Schmitz C; Michel A; Kipp M
    Mol Neurobiol; 2019 Feb; 56(2):1109-1123. PubMed ID: 29873041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis.
    Ballerini C; Aldinucci A; Luccarini I; Galante A; Manuelli C; Blandina P; Katebe M; Chazot PL; Masini E; Passani MB
    Br J Pharmacol; 2013 Sep; 170(1):67-77. PubMed ID: 23735232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine Regulates the Inflammatory Profile of SOD1-G93A Microglia and the Histaminergic System Is Dysregulated in Amyotrophic Lateral Sclerosis.
    Apolloni S; Fabbrizio P; Amadio S; Napoli G; Verdile V; Morello G; Iemmolo R; Aronica E; Cavallaro S; Volonté C
    Front Immunol; 2017; 8():1689. PubMed ID: 29250069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive human immunity drives remyelination in a mouse model of demyelination.
    El Behi M; Sanson C; Bachelin C; Guillot-Noël L; Fransson J; Stankoff B; Maillart E; Sarrazin N; Guillemot V; Abdi H; Cournu-Rebeix I; Fontaine B; Zujovic V
    Brain; 2017 Apr; 140(4):967-980. PubMed ID: 28334918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
    Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
    Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remyelination in multiple sclerosis: from concept to clinical trials.
    Kremer D; Göttle P; Flores-Rivera J; Hartung HP; Küry P
    Curr Opin Neurol; 2019 Jun; 32(3):378-384. PubMed ID: 30865009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
    Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
    J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of FXR by ganoderic acid A promotes remyelination in multiple sclerosis via anti-inflammation and regeneration mechanism.
    Jia Y; Zhang D; Li H; Luo S; Xiao Y; Han L; Zhou F; Wang C; Feng L; Wang G; Wu P; Xiao C; Yu H; Du J; Bao H
    Biochem Pharmacol; 2021 Mar; 185():114422. PubMed ID: 33482151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demyelination versus remyelination in progressive multiple sclerosis.
    Bramow S; Frischer JM; Lassmann H; Koch-Henriksen N; Lucchinetti CF; Sørensen PS; Laursen H
    Brain; 2010 Oct; 133(10):2983-98. PubMed ID: 20855416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors.
    Rankin KA; Mei F; Kim K; Shen YA; Mayoral SR; Desponts C; Lorrain DS; Green AJ; Baranzini SE; Chan JR; Bove R
    J Neurosci; 2019 Mar; 39(12):2184-2194. PubMed ID: 30696729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remodeling of the interstitial extracellular matrix in white matter multiple sclerosis lesions: Implications for remyelination (failure).
    de Jong JM; Wang P; Oomkens M; Baron W
    J Neurosci Res; 2020 Jul; 98(7):1370-1397. PubMed ID: 31965607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis.
    Navarrete C; García-Martin A; Garrido-Rodríguez M; Mestre L; Feliú A; Guaza C; Calzado MA; Muñoz E
    Neurobiol Dis; 2020 Sep; 143():104994. PubMed ID: 32599064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms underlying remyelination with special focus on demyelination models of multiple sclerosis].
    Zheng S; Zhao J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 49(4):524-530. PubMed ID: 32985167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.